POSB4 Effectiveness of Caplacizumab on Reducing Acute Mortality in Acquired Thrombotic Thrombocytopenic Purpura: Results from a French National Registry (CNR-MAT)
Jan 1, 2022, 00:00
10.1016/j.jval.2021.11.114
https://www.valueinhealthjournal.com/article/S1098-3015(21)01909-4/fulltext
Title :
POSB4 Effectiveness of Caplacizumab on Reducing Acute Mortality in Acquired Thrombotic Thrombocytopenic Purpura: Results from a French National Registry (CNR-MAT)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)01909-4&doi=10.1016/j.jval.2021.11.114
First page :
Section Title :
Open access? :
No
Section Order :
10759